Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa
Data up to Jan 2025
Total Citations Per Year
Abstract
References (141)
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
1995 • 8,575 citations
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 • 3,012 citations
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
1981 • 2,891 citations
World Cancer Report
2003 • 2,484 citations
Cancer burden in the year 2000. The global picture
2001 • 2,206 citations
Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children
1997 • 1,836 citations
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
1991 • 1,525 citations
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
1991 • 1,418 citations
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
2002 • 1,212 citations
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
2000 • 1,127 citations
p53 and Human Cancer: The First Ten Thousand Mutations
1999 • 968 citations
Global surveillance and control of hepatitis C
1999 • 909 citations
Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HB<sub>s</sub>Ag Subtypes
2004 • 836 citations
Global control of hepatitis B virus infection
2002 • 809 citations
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
1992 • 723 citations
Christianity and Democracy: The Global Picture
2004 • 703 citations
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
1994 • 668 citations
Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
1999 • 634 citations
The toxicology of aflatoxins: human health, veterinary and agricultural significance.
1993 • 586 citations
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.
1999 • 575 citations
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
2005 • 568 citations
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
1998 • 545 citations
Occult hepatitis B
2002 • 524 citations
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
2004 • 492 citations
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study
2002 • 470 citations
Modification of immune function through exposure to dietary aflatoxin in Gambian children.
2002 • 459 citations
Global surveillance and control of hepatitis C
1999 • 441 citations
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
2004 • 433 citations
The influence of age on the development of the hepatitis B carrier state
1993 • 402 citations
Cancer and infection: estimates of the attributable fraction in 1990.
1997 • 394 citations
Characteristics of patients with dual infection by hepatitis B and C viruses
1998 • 373 citations
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
2001 • 351 citations
What Level of Hepatitis B Antibody Is Protective?
1999 • 334 citations
Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa
2002 • 333 citations
Hepatitis B virus genotypes in the United States: results of a nationwide study
2003 • 314 citations
Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan
1996 • 296 citations
Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study
2005 • 291 citations
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
1994 • 282 citations
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)
2000 • 270 citations
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
2003 • 267 citations
Hepatocellular Carcinoma: From Gene to Public Health
1997 • 267 citations
High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black africans with hepatocellular carcinoma compared with asymptomatic carriers
1999 • 258 citations
Clinical significance of hepatitis B virus genotypes
2002 • 256 citations
Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats
1987 • 247 citations
Aflatoxin Exposure in Human Populations: Measurements and Relationship to Cancer
1988 • 235 citations
Primary prevention of hepatocellular carcinoma in developing countries
2000 • 231 citations
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China
2002 • 227 citations
The injection century: massive unsterile injections and the emergence of human pathogens
2001 • 218 citations
Pathogenesis of hepatitis C—associated hepatocellular carcinoma
2004 • 216 citations
Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan
2004 • 210 citations
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa
2004 • 208 citations
The aflatoxin B 1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma
2002 • 202 citations
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma
2000 • 197 citations
Hepatitis B Vaccination and Hepatocellular Carcinoma Rates in Boys and Girls
2000 • 195 citations
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.
1992 • 194 citations
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
2000 • 190 citations
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
2005 • 173 citations
Outbreak of Aflatoxin Poisoning - Eastern and Central Provinces, Kenya, January - July 2004
2004 • 164 citations
Specific mutations of hepatitis B virus in plasma predict liver cancer development
2004 • 162 citations
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr
1996 • 160 citations
Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children
2002 • 159 citations
Environmental and genetic determinants of aflatoxin-albumin adducts in The Gambia
2000 • 159 citations
Risk Factors for Horizontal Transmission of Hepatitis B Virus in a Rural District in Ghana
1998 • 158 citations
Hepatitis B vaccination in infancy in The Gambia: protection
1999 • 152 citations
Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan Africans
2005 • 151 citations
Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas
2004 • 150 citations
Prevention and control of hepatitis B in China
2002 • 149 citations
HEPATITIS B VIRUS INFECTION IN TWO GAMBIAN VILLAGES
1983 • 148 citations
Long‐Term Immunogenicity and Efficacy of Universal Hepatitis B Virus Vaccination in Taiwan
2002 • 141 citations
A novel hepatitis B virus variant in the sera of immunized children
1994 • 130 citations
Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children
1999 • 128 citations
Hepatitis B infection and aflatoxin biomarker levels in Gambian children
2000 • 125 citations
Needlestick Transmission of Hepatitis C
2002 • 123 citations
Aflatoxin—albumin adducts in human sera from different regions of the world
1990 • 122 citations
Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats
1986 • 121 citations
Aflatoxrn M1 in human breast milk from The Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC
1992 • 117 citations
Hepatitis B Vaccination in High‐Risk Infants: 10‐Year Follow‐Up
1999 • 115 citations
Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
2001 • 114 citations
Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity
2005 • 108 citations
Mutations of the surface protein of hepatitis B virus
2003 • 108 citations
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
2003 • 104 citations
Aflatoxin and liver cancer
1999 • 103 citations
Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
2001 • 103 citations
Polymorphisms in XRCC1 and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular Carcinoma
2003 • 103 citations
The Pattern of Childhood Hepatitis B Infection in Two Gambian Villages
1990 • 100 citations
Aflatoxin detected in human breast milk by immunoassay
1987 • 93 citations
Hepatitis B Vaccination and Hepatocellular Carcinoma in Taiwan
1997 • 93 citations
Breakthrough Infections and Identification of a Viral Variant in Gambian Children Immunized with Hepatitis B Vaccine
1994 • 90 citations
Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation
1993 • 90 citations
Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa
2004 • 89 citations
Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma
1998 • 83 citations
Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
1998 • 82 citations
Plasma Carotenoids, Glutathione S-Transferase M1 andT1 Genetic Polymorphisms, and Risk of Hepatocellular Carcinoma: Independent and Interactive Effects
1999 • 80 citations
Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes
2004 • 80 citations
Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children.
1993 • 79 citations
Risk factors for transmission of hepatitis B virus to Gambian children
1990 • 78 citations
An automated, handheld biosensor for aflatoxin
2000 • 76 citations
Impacts of chemicals on liver cancer risk
2000 • 74 citations
Cancer in The Gambia: 1988–97
2001 • 70 citations
Cost-effectiveness of hepatitis B vaccine in The Gambia
1993 • 66 citations
Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
1993 • 64 citations
Mouse models to study the interaction of risk factors for human liver cancer.
2003 • 63 citations
Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan
2003 • 61 citations
Hepatitis B 1762T/1764A Mutations, Hepatitis C Infection, and Codon 249 p53 Mutations in Hepatocellular Carcinomas from Thailand
2005 • 60 citations
Codon 249 mutation in exon 7 ofp53gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China
2003 • 60 citations
Nucleic acid sequence analysis of the precore region of hepatitis B virus from sera of southern African black adult carriers of the virus
1997 • 55 citations
Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand
1992 • 55 citations
The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group.
1987 • 52 citations
The first 2 years of the Gambian National Cancer Registry
1990 • 51 citations
Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver.
1982 • 51 citations
Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma
1996 • 50 citations
Quantitative Analysis of Plasma TP53 249Ser-Mutated DNA by Electrospray Ionization Mass Spectrometry
2005 • 49 citations
Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man
1998 • 44 citations
Do bedbugs transmit hepatitis B?
1994 • 44 citations
Persistent Hepatitis B Virus Infection and Hepatoma in The Gambia, West Africa
1992 • 43 citations
New immunization initiatives and progress toward the global control of hepatitis B
2002 • 41 citations
Detection of aflatoxins and related metabolites by radioimmunoassay.
1982 • 41 citations
High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis
2001 • 40 citations
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study
2002 • 38 citations
Molecular dosimetry methods for assessing human aflatoxin exposures.
1993 • 38 citations
Trials of intradermal hepatitis B vaccines in Gambian children
1987 • 37 citations
Hepatitis C Virus Infection, Linxian, China1
2005 • 33 citations
Absence of TP53 Codon 249 Mutations in Young Guinean Children with High Aflatoxin Exposure
2005 • 31 citations
Molecular epidemiology of human cancer
1998 • 31 citations
Strategies for chemoprevention of liver cancer.
2002 • 30 citations
Hepatocellular Carcinoma
2004 • 29 citations
Prevalence of HBV core promoter/precore/core mutations in Gambian chronic carriers
2001 • 27 citations
Molecular epidemiology and cancer: promising areas for future research in the post-genomic era
2002 • 26 citations
249serp53 mutation in the serum of black southern African patients with hepatocellular carcinoma
2005 • 25 citations
Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1.
2000 • 22 citations
Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage.
1999 • 19 citations
Immunoassay procedures to detect exposure to aflatoxin B1 and benzo(a)pyrene in animals and man at the DNA level
1988 • 19 citations
Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants
2001 • 18 citations
Molecular Dosimetry Methods for Assessing Human Aflatoxin Exposures
1994 • 16 citations
Molecular Dosimetry of Aflatoxin Exposure: Contribution to Understanding the Multifactorial Etiopathogenesis of Primary Hepatocellular Carcinoma with Particular Reference to Hepatitis B Virus
1993 • 11 citations
Codon 249 mutation in exon 7 of p53 gene in plasma DNA： maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China
2003 • 8 citations
The war against hepatitis B
1995 • 8 citations
Do bedbugs transmit hepatitis B?
1994 • 8 citations
Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area
2003 • 8 citations
The War Against Hepatitis B
1996 • 6 citations
Nucleic acid sequence analysis of the precore region of hepatitis B virus from sera of southern African black adult carriers of the virus
1997 • 3 citations